Holen Sie sich die Stockscreener-App
1.26
1.56%
-0.02
Handel nachbörslich:
1.29
0.03
+2.38%
Schlusskurs vom Vortag:
$1.28
Offen:
$1.28
24-Stunden-Volumen:
163.29K
Relative Volume:
0.25
Marktkapitalisierung:
$67.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-78.34M
KGV:
-0.8503
EPS:
-1.4819
Netto-Cashflow:
$-75.02M
1W Leistung:
-2.33%
1M Leistung:
-14.86%
6M Leistung:
-4.55%
1J Leistung:
+40.00%
1-Tages-Spanne:
$1.25
$1.31
1-Wochen-Bereich:
$1.22
$1.35
52-Wochen-Spanne:
$0.85
$1.88
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Firmenname
Pmv Pharmaceuticals Inc
Sektor
Branche
Telefon
(609) 642-6670
Adresse
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.26 | 68.26M | 0 | -78.34M | -75.02M | -1.4819 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-05-13 | Eingeleitet | Craig Hallum | Buy |
| 2024-04-12 | Eingeleitet | Jefferies | Buy |
| 2023-12-27 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-09-22 | Hochstufung | Goldman | Neutral → Buy |
| 2021-08-19 | Eingeleitet | Oppenheimer | Perform |
| 2021-08-02 | Eingeleitet | Guggenheim | Buy |
| 2021-07-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-10-20 | Eingeleitet | BofA Securities | Buy |
| 2020-10-20 | Eingeleitet | Cowen | Outperform |
| 2020-10-20 | Eingeleitet | Evercore ISI | Outperform |
| 2020-10-20 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Pmv Pharmaceuticals Inc Aktie (PMVP) Neueste Nachrichten
PMV Pharmaceuticals (PMVP) Slips to $1.26 as Cautious Trading Puts Support to the TestCalendar Spread Trade - Newser
PMV Pharmaceuticals, Inc.Common Stock (Nasdaq:PMVP) Stock Quote - FinancialContent
Number of shareholders of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Euclidean Capital reports 2.6M shares in PMVP (PMVP) - Stock Titan
PMV Pharmaceuticals (PMVP) Q1 2026 Earnings: Why the Beat MattersShared Trade Ideas - newser.com
PMV Pharmaceuticals (PMVP) price target decreased by 37.50% to 4.84 - MSN
PMVP Maintains Outperform Rating by Oppenheimer -- Price Target Lowered to $5.00 - GuruFocus
Oppenheimer Maintains PMV Pharmaceuticals(PMVP.US) With Buy Rating, Cuts Target Price to $5 - Moomoo
12 Health Care Stocks Moving In Wednesday's After-Market SessionAquestive Therapeutics (NASDAQ:AQST) - Benzinga
TradingKey - TradingKey
PMVP Advances PYNNACLE Study and NDA Submission Timeline - GuruFocus
PMV Pharmaceuticals Releases Q1 2026 Financial Results - AlphaStreet
PMV Pharmaceuticals stock (US7301281085): Q1 2026 results and rezatapopt orphan drug nod - AD HOC NEWS
PMV Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
PMV Pharmaceuticals 1Q Loss/Shr 34c >PMVP - Moomoo
PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlights - The Manila Times
PMV Pharmaceuticals' Q1 net loss widens - TradingView
PMV Pharmaceuticals 1Q 2026: Net loss $18M, EPS $(0.34) — 10-Q Summary - TradingView
PMV Pharmaceuticals 1Q Loss $18M >PMVP - Moomoo
PMV Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
8-K: PMV Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Highlightsmoomoo - Moomoo
PMV Pharmaceuticals (NASDAQ: PMVP) reports Q1 2026 loss and details rezatapopt progress - Stock Titan
PMV Pharmaceuticals (NASDAQ: PMVP) Q1 2026 loss, strong rezatapopt data and orphan status - Stock Titan
PMV Pharmaceuticals (PMVP) Eps Diluted (TTM) - Zacks Investment Research
PMV Pharmaceuticals Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView
Sio Capital (PMVP) discloses 3,076,580 shares, 5.77% stake in PMV Pharmaceuticals - Stock Titan
PMV Pharmaceuticals (PMVP) to Release Earnings on Friday - MarketBeat
PMVP PMV Pharmaceuticals beats Q4 2025 EPS estimates by 17.7 percent, shares hold steady in today’s trading.Pre Announcement - newser.com
Short Interest in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Increases By 48.3% - MarketBeat
PMV Pharmaceuticals (PMVP) posts narrower than expected Q4 2025 loss, shares rise 1.37 percent in today's trading.Community Exit Signals - Newser
Is PMV Pharmaceuticals (PMVP) stock priced below intrinsic value (Institutional Demand) 2026-04-22Social Buy Zones - Cổng thông tin điện tử tỉnh Lào Cai
PMV Pharmaceuticals names Laurie Stelzer as board chair - Investing.com
PMV Pharmaceuticals chair Rich Heyman to depart, Laurie Stelzer to succeed - TipRanks
PMV Pharmaceuticals names Laurie Stelzer as board chair By Investing.com - Investing.com Canada
[ARS] PMV Pharmaceuticals, Inc. SEC Filing - Stock Titan
PMV Pharmaceuticals Announces Board Chair Transition - Weekly Voice
The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform - Weekly Voice
As PMV nears a 2027 drug filing, its board chair changes hands - Stock Titan
Board shifts and pay vote in PMV Pharmaceuticals (NASDAQ: PMVP) 2026 proxy - Stock Titan
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Invest In Growth? - Yahoo Finance
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
PMV Pharmaceuticals (NASDAQ:PMVP) Stock Rating Upgraded by Evercore - MarketBeat
PMV Pharmaceuticals price target lowered to $4 from $16 at Evercore ISI - TipRanks
Stock List: Research Stocks from Around the World - GuruFocus
GUTS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Is PMV Pharmaceuticals (PMVP) Stock Breaking Resistance | Price at $1.29, Down 0.77%Crowd Entry Points - Newser
Energy Moves: Will PMV Pharmaceuticals Inc outperform its industry peers2026 Momentum & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Dividend Watch: Is PMV Pharmaceuticals Inc exposed to currency risksQuarterly Earnings Report & Daily Growth Stock Investment Tips - baoquankhu1.vn
Quarterly Recap: Is Edgewell Personal Care Company forming bullish engulfing patternsIPO Watch & Growth Focused Entry Reports - baoquankhu1.vn
PLRX PE Ratio & Valuation, Is PLRX Overvalued - Intellectia AI
PMVP Stock Analysis: PMV Pharmaceuticals Inc Biotech Performance At 1.34 Price - Newser
Finanzdaten der Pmv Pharmaceuticals Inc-Aktie (PMVP)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.98%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):